http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-225325-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eab56e4fe8837840887f41af83e328ee |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N57-12 |
| filingDate | 1984-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcfee0000aa52619c8f0c4797c62a1fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715062bd817547f59985e904c76b294b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8247e62c60820db2a0d7727b582225de |
| publicationDate | 1985-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-225325-A1 |
| titleOfInvention | BIOGENIC AGENTS FOR THE CHEMOTHERAPY OF VEGETABLE VIRUSES |
| abstract | The invention relates to biogenic agents for improved chemotherapy of plant viruses. The task is seen in the discovery of substances that are isolated from microorganisms in the context of biotechnological processes, do not belong to the antibiotics and inhibit the replication of plant viruses in conjunction with auxiliary and tracer substances. The object is achieved by the use of lipid extracts or fractions isolated therefrom, which are obtained in the fermentation of hydrocarbons from yeast biomasses and bacteria. Prevent or slow down on their basis produced Spritzbruehen, applied to virus gefaehrdete plants, the proliferation of a number of viruses, especially of viruses that are used in cultures of economically important nightshade, z. As potatoes, tomatoes or tobacco, causing damage. Combined application together with hydrogenated triazines and guanidines enhances antiphytoviral effects. Combined or alternating use of different preparations prevents the development of preventable viral stasis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2456305-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2456305-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010276286-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466192-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8957000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9832996-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9179675-B2 |
| priorityDate | 1984-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.